Willett Advisors
650 Madison Ave 17th Floor, New York, NY, 10022, United States
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Cellares | Jan 2026Participated | $257 MSeries D | |
Kinaset Therapeutics | Jan 2026Participated | $103 MSeries B | |
AAVantgarde Bio | Nov 2025Participated | $141 MSeries B | |
Antares Therapeutics | Jun 2025Participated | $177 MSeries A | |
Robin AI | Nov 2024Led | $25 MSeries B | |
Scorpion Therapeutics | Jul 2024Participated | $150 MSeries C | |
Remix Therapeutics | Jan 2024Participated | $60 MOther Equity | |
Cellares | Aug 2023Participated | $255 MSeries C | |
Carmot Therapeutics | May 2023Participated | $150 MSeries E | |
Carmot Therapeutics | Jul 2022Participated | $160 MSeries D | |
NextRNA Therapeutics | Mar 2022Participated | $56 MSeries A | |
Disc Medicine | Sep 2021Participated | $90 MSeries B | |
Cellares | Jan 2026Participated | $257 MSeries D | |
Kinaset Therapeutics | Jan 2026Participated | $103 MSeries B | |
AAVantgarde Bio | Nov 2025Participated | $141 MSeries B | |
Antares Therapeutics | Jun 2025Participated | $177 MSeries A | |
Robin AI | Nov 2024Led | $25 MSeries B | |
Scorpion Therapeutics | Jul 2024Participated | $150 MSeries C | |
Remix Therapeutics | Jan 2024Participated | $60 MOther Equity | |
Cellares | Aug 2023Participated | $255 MSeries C | |
Carmot Therapeutics | May 2023Participated | $150 MSeries E | |
Carmot Therapeutics | Jul 2022Participated | $160 MSeries D | |
NextRNA Therapeutics | Mar 2022Participated | $56 MSeries A | |
Disc Medicine | Sep 2021Participated | $90 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 0 | 2 |
| Series B | 1 | 5 |
| Series C+ | 0 | 8 |
| Other Equity | 0 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Mar '18 | 1 |
| Apr '18 | 0 |
| May '18 | 0 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 1 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 1 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 1 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 1 |
| Jun '21 | 0 |
| Jul '21 | 1 |
| Aug '21 | 0 |
| Sep '21 | 1 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 1 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 1 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 1 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 1 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 1 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 1 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 1 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 1 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 1 |
| Dec '25 | 0 |
| Jan '26 | 2 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 15 |
| AI & Machine Learning | 4 |
| Manufacturing | 3 |
| Enterprise Software | 2 |
| Professional Services | 2 |
| Crypto & Blockchain | 1 |
| Fintech | 1 |
| Transportation & Logistics | 1 |
| Developer Tools | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 0 |
| $25M-$50M | 2 |
| $50M-$100M | 6 |
| $100M-$250M | 7 |
| $250M-$500M | 3 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 16 |
| Europe | 2 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Atlas Venture | 6 |
| 5AM Ventures | 3 |
| Avenir | 3 |
| RA Capital Management | 3 |
| Shumway Capital | 3 |
| The Column Group | 3 |
| Abingworth | 2 |
| Alexandria Venture Investments | 2 |
| Casdin Capital | 2 |
| Decheng Capital | 2 |
| Deep Track Capital | 2 |
| DFJ Growth | 2 |
| Eclipse Ventures | 2 |
| Fidelity Management & Research Company | 2 |
| Frazier Life Sciences | 2 |
| Invus | 2 |
| Janus Henderson Investors | 2 |
| Lightspeed Venture Partners | 2 |
| Morgan Noble Healthcare Partners | 2 |
| OCV Partners | 2 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 1 | 6% |
| Participating | 17 | 94% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 1 | 100% |
Team
Managing Director of Private Equity
Chairman and Chief Executive Officer